b Tested in sodium chloride 0.9%.
c Tested in both dextrose 5% and sodium chloride 0.9%.
d Tested in dextrose 5% in sodium chloride 0.225%.
e Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.
f Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.
g Test performed using the formulation WITH edetate disodium.
h Tested with combination with sodium thiosulfate (Cangene Biopharma) 4 mg/mL.
i Tested with dopamine HCl (DCC) 3.2 mg/mL.
j Tested with lidocaine HCl (AB) 8 mg/mL.